Manifold Partners’s Gilead Sciences GILD Stock Holding History

Manifold Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,990	Closed	-$707K	–	56
2015 Q4	$707K	Hold	6,990	–	–	0.62%	18
2015 Q3	$686K	Buy	+6,990	New	+$776K	0.64%	17
2013 Q4	–	Sell	-1,550	Closed	-$97K	–	120
2013 Q3	$97K	Sell	1,550 -850	-35%	-$50.8K	0.06%	71
2013 Q2	$123K	Buy	+2,400	New	+$125K	0.09%	69

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Manifold Partners's GILD Position: Q1 2016 in Review

Manifold Partners sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 6,990 shares — an estimated $707K sold.

Manifold Partners first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $707K in Q4 2015. 1,632 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Manifold Partners reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Manifold Partners sold 6,990 Gilead Sciences shares in Q1 2016, an estimated $707K.
Manifold Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
Manifold Partners's Gilead Sciences position peaked at $707K in Q4 2015.
1,632 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Manifold Partners's 13F filing for Q1 2016, filed 2 Jun 2016.